References
- Rippon JW, Sporotrichosis. In: Rippon JW (ed) Medical mycology: the pathogenic fungi and the pathogenetic actinomycetes, 3rd ed. WB Saunders: Philadelphia, PA, 1988, pp. 325–52.
- Kauffman CA, Hajjeh R, Chapman SW, Practice guide- lines for the management of patients with sporotrichosis. Clin Infect Dis (2000) 30: 684–7.
- CA Kaufmann, Old and new therapies for sporotrichosis. Clin Infect Dis (1995) 21: 981–5.
- Sharkey-Mathis PK, Kauffman CA, Graybill JR et al, Treatment of sporotrichosis. Am J Med (1993) 95: 279– 85.
- Restrepo A, Robledo J, Gomez I et al, Itraconazole therapy in lymphangitic and cutaneous sporotrichosis. Arch Dermatol (1986) 122: 413–17.
- Conti Diaz IA, Civilia E, Gezuele E et al, Treatment of human sporotrichosis with itraconazole. Mycoses (1992) 35: 153–6.
- Winn RE, Anderson J, Piper J et al, Systemic sporotri- chosis treated with itraconazole. Clin Infect Dis (1993) 17: 210–17.
- Sterling BJ, Heymann WR, Potassium iodide in derma- tology: a 19th century drug for the 21st century: uses, pharmacology, adverse effects and contraindications. J Am Acad Dermatol (2000) 43: 691–7.
- Tio T, Vries G, Subcutaneous zygomycosis. S Afr Med J (1977) 52: 77–8.
- Rex JH, Bennett JE, Administration of potassium iodide to normal volunteers does not increase killing of Sporothrix schenckii by their neutrophils or monocytes. J Med Vet Mycol (1990) 28: 185–9.
- Honma K, Saga K, Onudera H, Takahashi M, Potassium iodide inhibits neutrophil chemotaxis. Acta Derm Venereol (1990) 70: 247–9.
- Miyachi Y, Niwa Y, Effects of potassium iodide, colchicine and dapsone on the generation of polymor- phonuclear leucocytes derived oxygen intermediates. Br J Dermatol (1982) 107: 209–14.
- Hiruma M, Kagawa S, Ultrastructure of Sporothrix schenckii with iodine–potassium iodide solution. Mycopathologica (1987) 97: 121–7.